Dyania Health
About Dyania Health
Dyania Health is a pioneering healthcare AI company that leverages its proprietary Synapsis AI platform to revolutionize clinical research and patient care. The platform utilizes advanced natural language processing (NLP) and machine learning to rapidly analyze electronic medical records (EMRs), including both structured and unstructured data like physician notes, pathology reports, and imaging notes. This technology enables the automated interpretation of EMRs in a fraction of the time it would take human medical professionals, with reported accuracy rates of approximately 95%.
For physicians and healthcare systems, Dyania Health’s Synapsis AI offers significant advantages by streamlining numerous time-consuming processes. It facilitates patient eligibility screening for clinical trials, automates chart review for observational studies and registry reporting, and helps identify therapeutic gaps and measure quality of care. The platform is designed to work within a healthcare system’s firewall, ensuring data security and privacy by processing AI locally. By automating these tasks, Dyania Health aims to reduce administrative burden, optimize resource allocation, and ultimately enhance patient outcomes by enabling faster access to innovative therapies and more personalized, evidence-based care pathways.
The company’s multidisciplinary team, composed of clinicians, NLP applied scientists, and engineers, is crucial to its competitive edge. They work collaboratively to build and train Synapsis AI, ensuring its medical-grade performance across various disease-specific use cases, including oncology, cardiology, and autoimmune conditions. Dyania Health’s solutions are designed to empower healthcare providers with actionable insights, allowing them to make informed decisions and improve patient care.
Focus Areas
Business Intelligence
| Key Investors | HealthX Ventures, Tech Square Ventures, Cleveland Clinic Ventures, Motivate Ventures, Tau Ventures, Stage Venture Partners, CancerX (USA), Big Pi Ventures, Gaingels, Founder Equity Fund, Wedbush Ventures, Innospark Ventures, 406 Ventures, Glasswing Ventures |
| Partnerships | Cleveland Clinic |
| Technology | Synapsis AI, a proprietary LLM-based end-to-end platform that leverages advanced natural language processing (NLP) and data engineering to analyze structured and unstructured electronic medical record (EMR) data. It operates as a closed system within a health system's private network. |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
Dyania Health's Synapsis AI platform empowers physicians by dramatically increasing their capacity to review and analyze patient data. It allows them to interrogate patient data with complex clinical questions and receive answers with unprecedented inference and reasoning capabilities. The system provides granular explainability, pinpointing the exact part of the medical record that led to the AI's conclusion, fostering trust and informed decision-making. This means physicians can identify eligible patients for clinical trials much faster, support observational studies, and automate registry reporting, ultimately allowing them to be more effective in patient care and research.
Dyania Health's Synapsis AI platform is designed for end-to-end deployment within healthcare system firewalls, ensuring data privacy and compliance with regulations like HIPAA and GDPR. The software operates as a closed system within a health system's private network, meaning patient data never leaves the healthcare system's computing environment. The integration process involves collaboration between Dyania physicians, engineers, and the healthcare system's leadership and IT professionals for protocol scoping, deployment, and data ingestion.
What the Web Says
Dyania Health, founded in 2020, is an AI-driven healthcare data company that specializes in automating the manual review of electronic medical records (EMRs) with its proprietary Synapsis AI platform. This technology aims to accelerate clinical trials, enhance patient care, and improve the efficiency of medical research by processing EMRs in a fraction of the time it would take a human. The company has secured $10 million in Series A funding to expand its AI capabilities and partnerships. While there are limited direct product reviews for Dyania Health's Synapsis AI on major review platforms like G2 and Capterra, the company's employer reviews on Indeed and SimplyHired show a mixed but generally positive sentiment, highlighting a mission-driven culture and opportunities for growth alongside some concerns about disorganization and management.
Overall: MixedStrengths
- Automates manual review of EMRs, significantly reducing processing time (e.g., from hours to half a second).
- Enhances clinical research, reporting, and quality of care.
- Platform operates within healthcare systems' firewalls, ensuring data privacy and HIPAA/GDPR compliance.
- Mission-driven organization with a passionate and collaborative team.
- Supportive leadership that cares about employee growth and well-being.
- Opportunities for career growth and a dynamic work environment.
Limitations
- Limited direct product reviews available on major platforms like G2 and Capterra.
- Some employee reviews mention disorganization and unprofessionalism.
- Concerns about management being business-focused rather than healthcare-focused.
- One review mentions a micromanaging CEO.
- Challenges in managing competing priorities in a fast-paced environment.
- Some employee feedback indicates a need for improvement in inclusive work environment, fair pay, and trust in colleagues.
Based on reviews from: Indeed.com, Elion, Fierce Healthcare, HIT Consultant, RamaOnHealthcare, YouTube, SimplyHired, G2.com
Last updated: 2026-09-05
Videos
News, demos, and interviews about Dyania Health.
Videos load interactively. If none appear, search YouTube for Dyania Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Dyania Health.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]